Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...

The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company ...

Sirona is a dual-polymer hydrogel pill that expands in the stomach, reducing appetite. Participants consumed 400 fewer ...